B Cell Lymphoma

Conference Coverage

Decoding biosimilar approvals

SAN FRANCISCO – Regulators must consider several factors when expanding the use of an approved biosimilar from one indication to another, based on...


Could home care replace inpatient HSCT?

Researchers are conducting phase 2 trials comparing patients who receive all posttransplant care at home with patients treated in the hospital or...